Last update :
18/04/2024
References   References 3250  
Type : Manufacturer

Research teams :
Authors :
Title : Eribulin (Halaven®) - Summary of Product Characteristics.
Reference : Eisai Ltd 2011

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionEribulin mesylate Anticancer drug
Stability in solutions Not specified Sodium chloride 0,9% 0,018 >> 0,18 mg/ml 2-8°C Not specified
24 Hour

  Mentions Légales